Scientific Program



 Friday, September 23, 2016
   
08:30-10:15 
Session 1: Introduction - Genetics 101
  Chairs: Simon Fishel, UK; Yuval Yaron, Israel; Tony Borrell, Spain
  
08:30-08:45                   
 
Welcomes
Simon Fishel, UK and Tony Borrell, Spain
  
08:45-09:15
 

Basic genetic principles for the non-geneticist
Yuval Yaron, Israel
   
09:15-09:45
 
 
Traditional genetic technologies
Vincenzo Cirigliano, Spain
  
09:45-10:15
 
 
Next generation sequencing: Strategies for genetic testing
Mark Hughes, USA
  
10:15-10:45
  
Coffee Break and Poster Viewing
  
10:45-11:45
Session 2: Preconception screening and preimplantation genetic diagnosis
  Chairs: Richard Scott, USA; Ariel Weissman, Israel
  
10:45-11:15
 
 
Single gene PGD with/without simultaneous PGS-aneuploidy screening
Mark Hughes, USA
   
11:15-11:45
 
 
Use of next generation sequencing for translocation carrier PGD
Tony Gordon, UK
 
11:45-13:15
  
Industry-Sponsored Symposium
 
13:15-14:00
 
Lunch Break
  
14:00-15:30 Session 3: Introduction to Preimplantation genetic screening (PGS)
  Chairs: Mark Hughes, USA; Alan Handyside, UK
 
14:00-14:30
   
 
  
Aneuploidy and mosaicism in human embryos

Santiago Munne, USA
   
14:30-15:00
 
Overview of PGS technologies
Nathan Treff, USA
 
15:00-15:30
  
  

Choice of patient of PGS?
Richard Scott, USA

  
15:30-16:00
 
Coffee Break and Poster Viewing
 
16:00-17:00 Session 4: Preimplantation genetic screening (PGS)
  Chairs: Santiago Munne, USA; Ariel Horowitz, Israel
 
16:00-16:30
 
  
Results of the Virtual Academy of Genetics (VAoGEN) questionnaire on PGS
Ariel Weismann, Israel
  
16:30-17:00
 
  
The use of polar bodies for the analysis of oocyte ploidy
Alan Handyside, UK
 
17:00-18:00
Session 5: PGS - Debate
    
Debate: The 2015 COGEN Consensus Statement on PGS was not premature as PGS is advantageous to patients and is not potentially harmful

  
Moderator: Darren Griffin, UK
For: David McCulloh, USA
Against: Norbert Gleicher, USA
     
    
18:00-19:00 Informal Meet & Greet between Faculty and Participants 
 
   
 
Saturday, September 24, 2016
   
08:30-10:00
Session 6: Carrier screening and Personalized medicine
  Chair: Eugene Pergament, USA
 
08:30-09:00
 
Carrier screening of recessive disease - targeted vs. expanded carrier screening
Jim Goldberg, USA
08:00-09:30
 
  
 
Annexin A5 M2 Haplotype as a biomarker for antithrombotic treatment to improve pregnancy outcome
Simon Fishel, UK
  
09:30-10:00
 
 
Carrier screening
Julio Martin, Spain
  
10:00-10:30
 
Coffee Break & Poster Viewing
 
10:30-12:00 Session 7: Prenatal diagnosis
  Chairs: Peter Benn, UK; Howard Cuckle, USA
  
10:30-11:00
   
 
 
The origin of aneuploidy
Eugene Pergament, USA
  
11:00-11:30
 
 
Clinical indications for genomic microarray in Fetal Medicine 
Tony Borrell, Spain
  

11:30-12:00
 
 
From fetal CMA to fetal exomes
Ron Wapner, USA
 
12:00-13:15 Session 8: Prenatal diagnosis
  Chairs: Francesca Grati, Italy; Tony Borrell, Spain
  
12:00-12:25
  
 
  
NIPD for single-gene disorders
Fiona McCay, UK
  
12:25-12:50
 
  
Clinical utility and costs of NIPT in the general pregnancy population
Emilia Kostenko, Austria
  
12:50-13:15
 
 
 
Non-invasive prenatal testing (NIPT) for the rare chromosomal abnormalities:
Prospects and challenges

Peter Benn, UK
  
13:15-14:00
 
Lunch Break
 
14:00-15:45 Session 9: Prenatal diagnosis
  Chair: Jim Goldberg, USA, Shlomo Mashiach, Israel
  
14:00-14:25
 
 
Validation of Clarigo, the decentralized NIPT solution, in an international multi-center study
Jessie Theuns, Belgium

   
14:25-14:50
 
  
NIPT and mosaics: How to deal with the discordant results?
Francesca Grati, Italy
 
14:50-15:15
 
 
Biochemical screening in the NIPT era
Howard Cuckle, USA
 
15:15-15:45
   
   
Genetic counseling issues
Karen Sage
, UK
  
15:45-16:15
 
Coffee Break & Poster Viewing
  
16:15-17:45 Session 10: Genetics in reproduction
  Chairs: Simon Fishel, UK and Yuval Yaron, Israel
  
16:15-16:40
  
 
Genetics of hyperstimulation syndrome and primary ovarian failure
Micheline Misrahi, France
 
16:40-17:05
 
 
Cumulus cell genomics and its predictive value
Samir Hamamah, France
  
17:05-17:30
 
 
 
Blastocoel analysis for PGS and the potential clinical value of mitochondrial screening assays
Luca Gianaroli, Italy
 
17:30-17:45
 
 
Closing remarks
Yuval Yaron, Israel